Nabil, G.; Alzhrani, R.; Alsaab, H.O.; Atef, M.; Sau, S.; Iyer, A.K.; Banna, H.E.
CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer. Cancers 2021, 13, 898.
https://doi.org/10.3390/cancers13040898
AMA Style
Nabil G, Alzhrani R, Alsaab HO, Atef M, Sau S, Iyer AK, Banna HE.
CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer. Cancers. 2021; 13(4):898.
https://doi.org/10.3390/cancers13040898
Chicago/Turabian Style
Nabil, Ghazal, Rami Alzhrani, Hashem O. Alsaab, Mohammed Atef, Samaresh Sau, Arun K. Iyer, and Hossny El Banna.
2021. "CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer" Cancers 13, no. 4: 898.
https://doi.org/10.3390/cancers13040898
APA Style
Nabil, G., Alzhrani, R., Alsaab, H. O., Atef, M., Sau, S., Iyer, A. K., & Banna, H. E.
(2021). CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer. Cancers, 13(4), 898.
https://doi.org/10.3390/cancers13040898